ID
22328
Description
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, This form is to be performed in/after Screening Period 1, Weeks 2, 1 Month +/- 3 Days, 2 Months, 4 Months, 6 Months +/- 1 week, 8 Months, 10 Months, 12 Months +/- 1 week and Follow Up. Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1
Lien
https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1
Mots-clés
Versions (2)
- 30/05/2017 30/05/2017 -
- 30/05/2017 30/05/2017 -
Téléchargé le
30 mai 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Dosing and Compliance Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
Dosing and Compliance Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
Description
Investigational Product Compliance
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C1321605
Description
Investigational Product
Type de données
text
Alias
- UMLS CUI [1]
- C0304229
Description
Start date
Type de données
date
Unités de mesure
- dd/mm/yy
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0304229
Description
Stop Date
Type de données
date
Unités de mesure
- dd/mm/yy
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C0304229
Description
IP Container No.
Type de données
float
Alias
- UMLS CUI [1,1]
- C0180098
- UMLS CUI [1,2]
- C0304229
Description
Total number of Tablets Dispensed
Type de données
float
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0039225
Description
Total number of Tablets Returned
Type de données
float
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0039225
Description
Discontinuation
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0304229
Similar models
Dosing and Compliance Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148
C0011008 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0040223 (UMLS CUI [2,2])
C0237753 (UMLS CUI [1,2])
C1321605 (UMLS CUI-2)
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])